MyFinsight
Home
Blog
About
Cash, cash
equivalents, and restricted...
$690,915K
(-4.10%↓ Y/Y)
Supplies
$123,791K
(204.81%↑ Y/Y)
Accounts receivable
$116,888K
(129.69%↑ Y/Y)
Short-term marketable
securities
$102,200K
(4444.24%↑ Y/Y)
Prepaid expenses and
other current assets
$24,034K
(25.67%↑ Y/Y)
Total current assets
$1,057,828K
(26.94%↑ Y/Y)
Property and equipment,
net
$95,716K
(56.11%↑ Y/Y)
Other assets
$56,732K
(38.10%↑ Y/Y)
Goodwill
$19,344K
(0.00%↑ Y/Y)
Total assets
$1,229,620K
(28.75%↑ Y/Y)
Total liabilities and
shareholders' equity
$1,229,620K
(28.75%↑ Y/Y)
Total liabilities
$637,886K
(27.03%↑ Y/Y)
Total shareholders'
equity
$591,734K
(30.65%↑ Y/Y)
Accumulated deficit
-$2,549,883K
(3.96%↑ Y/Y)
Long-term indebtedness,
net of debt...
$392,973K
(5.18%↑ Y/Y)
Total current
liabilities
$191,437K
(112.28%↑ Y/Y)
Other long-term
liabilities
$53,476K
(39.39%↑ Y/Y)
Additional paid-in capital
$3,140,805K
(0.54%↑ Y/Y)
Accumulated other
comprehensive income
$529K
(-20.93%↓ Y/Y)
Common stock
$283K
(0.35%↑ Y/Y)
Accrued expenses and
other current...
$105,273K
(71.57%↑ Y/Y)
Accounts payable
$85,986K
(199.31%↑ Y/Y)
Current portion of
indebtedness
$178K
(87.37%↑ Y/Y)
Back
Back
Balance Sheet
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)
TN0277-v12_How-To-Order-1(1)
Caris Life Sciences, Inc. (CAI)
source: myfinsight.com